• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于结构的膳食食物多酚中半乳糖凝集素-1 选择性调节剂的鉴定:一种计算药物化学方法。

Structure-based identification of galectin-1 selective modulators in dietary food polyphenols: a pharmacoinformatics approach.

机构信息

Department of Chemical Technology, University of Calcutta, 92, A.P.C. Road, Kolkata, 700009, India.

Nutrition and Food Science, Department of Physical Sport Science, Princess Nourah Bint Abdulrahman University, P.O. Box 84428, Riyadh, 11671, Saudi Arabia.

出版信息

Mol Divers. 2022 Jun;26(3):1697-1714. doi: 10.1007/s11030-021-10297-1. Epub 2021 Sep 5.

DOI:10.1007/s11030-021-10297-1
PMID:34482478
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9209356/
Abstract

In this study, a set of dietary polyphenols was comprehensively studied for the selective identification of the potential inhibitors/modulators for galectin-1. Galectin-1 is a potent prognostic indicator of tumor progression and a highly regarded therapeutic target for various pathological conditions. This indicator is composed of a highly conserved carbohydrate recognition domain (CRD) that accounts for the binding affinity of β-galactosides. Although some small molecules have been identified as galectin-1 inhibitors/modulators, there are limited studies on the identification of novel compounds against this attractive therapeutic target. The extensive computational techniques include potential drug binding site recognition on galectin-1, binding affinity predictions of ~ 500 polyphenols, molecular docking, and dynamic simulations of galectin-1 with selective dietary polyphenol modulators, followed by the estimation of binding free energy for the identification of dietary polyphenol-based galectin-1 modulators. Initially, a deep neural network-based algorithm was utilized for the prediction of the druggable binding site and binding affinity. Thereafter, the intermolecular interactions of the polyphenol compounds with galectin-1 were critically explored through the extra-precision docking technique. Further, the stability of the interaction was evaluated through the conventional atomistic 100 ns dynamic simulation study. The docking analyses indicated the high interaction affinity of different amino acids at the CRD region of galectin-1 with the proposed five polyphenols. Strong and consistent interaction stability was suggested from the simulation trajectories of the selected dietary polyphenol under the dynamic conditions. Also, the conserved residue (His44, Asn46, Arg48, Val59, Asn61, Trp68, Glu71, and Arg73) associations suggest high affinity and selectivity of polyphenols toward galectin-1 protein.

摘要

在这项研究中,全面研究了一组膳食多酚,以选择性鉴定半乳糖凝集素-1的潜在抑制剂/调节剂。半乳糖凝集素-1是肿瘤进展的有力预后指标,也是各种病理状况的高度受关注的治疗靶点。该指标由高度保守的碳水化合物识别结构域(CRD)组成,该结构域决定了β-半乳糖苷的结合亲和力。尽管已经鉴定出一些小分子作为半乳糖凝集素-1抑制剂/调节剂,但针对该有吸引力的治疗靶点,鉴定新型化合物的研究有限。广泛的计算技术包括对半乳糖凝集素-1上潜在药物结合位点的识别、对约 500 种多酚的结合亲和力预测、分子对接以及对半乳糖凝集素-1与选择性膳食多酚调节剂的动态模拟,然后估算结合自由能,以鉴定基于膳食多酚的半乳糖凝集素-1调节剂。最初,使用基于深度神经网络的算法对半乳糖凝集素-1的可成药性结合位点和结合亲和力进行预测。此后,通过超高精度对接技术,对半乳糖凝集素-1与多酚化合物的分子间相互作用进行了深入探讨。此外,通过常规的原子 100ns 动力学模拟研究评估了相互作用的稳定性。对接分析表明,不同的多酚化合物与半乳糖凝集素-1的 CRD 区域的不同氨基酸具有高相互作用亲和力。在动态条件下,所选膳食多酚的模拟轨迹表明相互作用具有很强的稳定性。此外,保守残基(His44、Asn46、Arg48、Val59、Asn61、Trp68、Glu71 和 Arg73)的相互作用表明多酚对半乳糖凝集素-1蛋白具有高亲和力和选择性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e49/9209356/f071f6b5d85b/11030_2021_10297_Fig13_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e49/9209356/a0f5aac04da6/11030_2021_10297_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e49/9209356/2f4f42debcee/11030_2021_10297_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e49/9209356/c1a81acc52cd/11030_2021_10297_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e49/9209356/c8bae68ffac0/11030_2021_10297_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e49/9209356/783112e885e5/11030_2021_10297_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e49/9209356/5e8664406531/11030_2021_10297_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e49/9209356/ec2cc9641c8b/11030_2021_10297_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e49/9209356/a9410fe9a922/11030_2021_10297_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e49/9209356/c6366308ab05/11030_2021_10297_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e49/9209356/cf15de72aaec/11030_2021_10297_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e49/9209356/161d94024fb2/11030_2021_10297_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e49/9209356/696be0fef1f9/11030_2021_10297_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e49/9209356/f071f6b5d85b/11030_2021_10297_Fig13_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e49/9209356/a0f5aac04da6/11030_2021_10297_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e49/9209356/2f4f42debcee/11030_2021_10297_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e49/9209356/c1a81acc52cd/11030_2021_10297_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e49/9209356/c8bae68ffac0/11030_2021_10297_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e49/9209356/783112e885e5/11030_2021_10297_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e49/9209356/5e8664406531/11030_2021_10297_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e49/9209356/ec2cc9641c8b/11030_2021_10297_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e49/9209356/a9410fe9a922/11030_2021_10297_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e49/9209356/c6366308ab05/11030_2021_10297_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e49/9209356/cf15de72aaec/11030_2021_10297_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e49/9209356/161d94024fb2/11030_2021_10297_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e49/9209356/696be0fef1f9/11030_2021_10297_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e49/9209356/f071f6b5d85b/11030_2021_10297_Fig13_HTML.jpg

相似文献

1
Structure-based identification of galectin-1 selective modulators in dietary food polyphenols: a pharmacoinformatics approach.基于结构的膳食食物多酚中半乳糖凝集素-1 选择性调节剂的鉴定:一种计算药物化学方法。
Mol Divers. 2022 Jun;26(3):1697-1714. doi: 10.1007/s11030-021-10297-1. Epub 2021 Sep 5.
2
Structural insights in galectin-1-glycan recognition: Relevance of the glycosidic linkage and the N-acetylation pattern of sugar moieties.半乳糖凝集素-1 与糖识别的结构见解:糖基连接和糖部分 N-乙酰化模式的相关性。
Bioorg Med Chem. 2021 Aug 15;44:116309. doi: 10.1016/j.bmc.2021.116309. Epub 2021 Jul 14.
3
Bergenin: a computationally proven promising scaffold for novel galectin-3 inhibitors.岩白菜素:一种经计算验证的新型半乳糖凝集素-3抑制剂的有前景的骨架。
J Mol Model. 2018 Oct 2;24(10):302. doi: 10.1007/s00894-018-3831-4.
4
Computational studies of human galectin-1: role of conserved tryptophan residue in stacking interaction with carbohydrate ligands.人类半乳糖凝集素-1的计算研究:保守色氨酸残基在与碳水化合物配体堆积相互作用中的作用。
J Biomol Struct Dyn. 2009 Aug;27(1):49-58. doi: 10.1080/07391102.2009.10507295.
5
Further evidence by site-directed mutagenesis that conserved hydrophilic residues form a carbohydrate-binding site of human galectin-1.定点诱变提供的进一步证据表明,保守的亲水性残基构成了人半乳糖凝集素-1的碳水化合物结合位点。
Glycoconj J. 1994 Oct;11(5):437-42. doi: 10.1007/BF00731280.
6
Enzymatic synthesis of non-natural trisaccharides and galactosides; Insights of their interaction with galectins as a function of their structure.非天然三糖和半乳糖苷的酶促合成;关于它们与半乳糖凝集素相互作用与其结构关系的见解。
Carbohydr Res. 2019 Jan 15;472:1-15. doi: 10.1016/j.carres.2018.10.011. Epub 2018 Nov 3.
7
Investigating carbohydrate based ligands for galectin-3 with docking and molecular dynamics studies.通过对接和分子动力学研究来探究基于碳水化合物的半乳糖凝集素-3配体。
J Mol Graph Model. 2017 Jan;71:211-217. doi: 10.1016/j.jmgm.2016.10.018. Epub 2016 Nov 25.
8
Investigations on the binding specificity of β-galactoside analogues with human galectin-1 using molecular dynamics simulations.利用分子动力学模拟研究β-半乳糖苷类似物与人半乳糖凝集素-1的结合特异性
J Biomol Struct Dyn. 2022;40(20):10094-10105. doi: 10.1080/07391102.2021.1939788. Epub 2021 Jul 5.
9
Identification of polyphenols from as SARS CoV-2 main protease inhibitors using docking and molecular dynamics simulation approaches.基于对接和分子动力学模拟方法鉴定 中的多酚类化合物作为 SARS CoV-2 主蛋白酶抑制剂。
J Biomol Struct Dyn. 2021 Oct;39(17):6747-6760. doi: 10.1080/07391102.2020.1802347. Epub 2020 Aug 7.
10
Disaccharide binding to galectin-1: free energy calculations and molecular recognition mechanism.二糖与半乳糖凝集素-1 的结合:自由能计算与分子识别机制。
Biophys J. 2011 May 4;100(9):2283-92. doi: 10.1016/j.bpj.2011.03.032.

本文引用的文献

1
Aromatic heterocycle galectin-1 interactions for selective single-digit nM affinity ligands.用于选择性单纳米摩尔亲和力配体的芳香杂环半乳糖凝集素-1相互作用
RSC Adv. 2018 Jul 11;8(44):24913-24922. doi: 10.1039/c8ra04389b. eCollection 2018 Jul 9.
2
Pharmacoinformatics approach based identification of potential Nsp15 endoribonuclease modulators for SARS-CoV-2 inhibition.基于药物信息学的方法鉴定新型 SARS-CoV-2 Nsp15 内切核酸酶抑制剂。
Arch Biochem Biophys. 2021 Mar 30;700:108771. doi: 10.1016/j.abb.2021.108771. Epub 2021 Jan 21.
3
Multi-step molecular docking and dynamics simulation-based screening of large antiviral specific chemical libraries for identification of Nipah virus glycoprotein inhibitors.
基于多步分子对接和动力学模拟的大型抗病毒特定化学文库筛选,以鉴定尼帕病毒糖蛋白抑制剂。
Biophys Chem. 2021 Mar;270:106537. doi: 10.1016/j.bpc.2020.106537. Epub 2020 Dec 27.
4
identification of small molecule modulators for disruption of Hsp90-Cdc37 protein-protein interaction interface for cancer therapeutic application.鉴定小分子调节剂以破坏热休克蛋白 90-Cdc37 蛋白-蛋白相互作用界面,用于癌症治疗应用。
J Biomol Struct Dyn. 2022 Mar;40(5):2082-2098. doi: 10.1080/07391102.2020.1835714. Epub 2020 Oct 23.
5
Targeting Galectins With Glycomimetics.用糖模拟物靶向半乳糖凝集素
Front Chem. 2020 Aug 7;8:593. doi: 10.3389/fchem.2020.00593. eCollection 2020.
6
De novo design based identification of potential HIV-1 integrase inhibitors: A pharmacoinformatics study.基于从头设计的潜在HIV-1整合酶抑制剂的鉴定:一项药物信息学研究。
Comput Biol Chem. 2020 Oct;88:107319. doi: 10.1016/j.compbiolchem.2020.107319. Epub 2020 Jun 23.
7
Identification of potential anti-TMPRSS2 natural products through homology modelling, virtual screening and molecular dynamics simulation studies.通过同源建模、虚拟筛选和分子动力学模拟研究鉴定潜在的抗TMPRSS2天然产物。
J Biomol Struct Dyn. 2020 Aug 3;39(17):6660-6675. doi: 10.1080/07391102.2020.1798813.
8
Impact of Galectins in Resistance to Anticancer Therapies.半乳糖凝集素在抗癌治疗耐药性中的作用
Clin Cancer Res. 2020 Dec 1;26(23):6086-6101. doi: 10.1158/1078-0432.CCR-18-3870. Epub 2020 Jul 24.
9
Structure-Based Screening of DNA GyraseB Inhibitors for Therapeutic Applications in Tuberculosis: a Pharmacoinformatics Study.基于结构的结核分枝杆菌 DNA 回旋酶 B 抑制剂的筛选:药物信息学研究。
Appl Biochem Biotechnol. 2020 Dec;192(4):1107-1123. doi: 10.1007/s12010-020-03374-y. Epub 2020 Jul 20.
10
Galectins as Checkpoints of the Immune System in Cancers, Their Clinical Relevance, and Implication in Clinical Trials.半乳糖凝集素作为癌症免疫系统的检查点:其临床意义及在临床试验中的应用。
Biomolecules. 2020 May 12;10(5):750. doi: 10.3390/biom10050750.